—
Enter label dose
Trial reference
From your label
Enter your label dose — the gauge updates instantly.
2 g/day of branded Magtein in adults aged 18-45 reporting unsatisfying sleep. Overall cognition improved (NIH Total Cognition Composite, p = 0.043) along with reaction time, resting heart rate and HRV. Raven's matrices did not change, and neither did objective sleep from a wearable — only self-reported sleep-related impairment.
Educational only — not medical advice. Disclaimer.
NIH DSLD market slice
Bulk CSV dump 16 January 2026 · label entries through 2025. Disclosed amounts only — proprietary blends without gram weights excluded.
Trial floors
Primary
Cognition and sleep trial (compound weight) · 2,000 mg over 6 weeks · Secondary outcomes only — 2 g/day of branded Magtein in adults aged 18-45 reporting unsatisfying sleep. Overall cognition improved (NIH Total Cognition Composite, p = 0.043) along with reaction time, resting heart rate and HRV. Raven's matrices did not change, and neither did objective sleep from a wearable — only self-reported sleep-related impairment.
Label reading notes
- This dose is compound weight, not elemental magnesium. 2000 mg of magnesium L-threonate carries roughly 144 mg of elemental magnesium — about a third of the daily value, not a large dose.
- Compare it against the elemental magnesium entry before deciding you are covered: a big number on a threonate label is not a big magnesium dose.
- The trial used the branded Magtein preparation. Generic magnesium L-threonate at the same milligram count has no separate trial.
- Cognitive endpoints were mixed — one composite met significance, one reasoning test did not, and objective sleep did not move.
